Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 10 (7)

Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective

Affiliations
Review

Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective

Mohammad Hosein Farzaei et al. Nutrients.

Abstract

Oxidative stress has been considered a key causing factor of liver damage induced by a variety of agents, including alcohol, drugs, viral infections, environmental pollutants and dietary components, which in turn results in progression of liver injury, non-alcoholic steatohepatitis, non-alcoholic liver disease, liver fibrosis and cirrhosis. During the past 30 years and even after the major progress in the liver disease management, millions of people worldwide still suffer from an acute or chronic liver condition. Curcumin is one of the most commonly used indigenous molecules endowed by various shielding functionalities that protects the liver. The aim of the present study is to comprehensively review pharmacological effects and molecular mechanisms, as well as clinical evidence, of curcumin as a lead compound in the prevention and treatment of oxidative associated liver diseases. For this purpose, electronic databases including “Scopus,” “PubMed,” “Science Direct” and “Cochrane library” were extensively searched with the keywords “curcumin or curcuminoids” and “hepatoprotective or hepatotoxicity or liver” along with “oxidative or oxidant.” Results showed that curcumin exerts remarkable protective and therapeutic effects of oxidative associated liver diseases through various cellular and molecular mechanisms. Those mechanisms include suppressing the proinflammatory cytokines, lipid perodixation products, PI3K/Akt and hepatic stellate cells activation, as well as ameliorating cellular responses to oxidative stress such as the expression of Nrf2, SOD, CAT, GSH, GPx and GR. Taking together, curcumin itself acts as a free radical scavenger over the activity of different kinds of ROS via its phenolic, β-diketone and methoxy group. Further clinical studies are still needed in order to recognize the structure-activity relationships and molecular mechanisms of curcumin in oxidative associated liver diseases.

Keywords: curcumin; hepatotoxicity; liver diseases; oxidative stress; systematic review.

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Study selection diagram.
Figure 2
Figure 2
Cellular and molecular mechanisms of curcumin in the prevention of oxidative-associated liver disease. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), reactive oxygen species (ROS), sulfasalazine reduces superoxide dismutase (SOD), glutathione (GSH), glutathione reductase (GR), malondialdehyde (MDA), catalase (CAT), inducible nitric oxide (iNOS), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), extracellular signal-regulated kinases (ERK), mitogen-activated protein kinase (MAPK).

Similar articles

See all similar articles

Cited by 19 PubMed Central articles

See all "Cited by" articles

References

    1. Muriel P. Liver Pathophysiology. Elsevier; Amsterdam, The Netherlands: 2017. The Liver: General Aspects and Epidemiology; pp. 3–22.
    1. Cichoż-Lach H., Michalak A. Oxidative Stress as a Crucial Factor in Liver Diseases. World J. Gastroenterol. 2014;20:8082. doi: 10.3748/wjg.v20.i25.8082. - DOI - PMC - PubMed
    1. Clark A.M. Natural products as a resource for new drugs. Pharm. Res. 1996;13:1133–1141. doi: 10.1023/A:1016091631721. - DOI - PubMed
    1. Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov. Today. 2000;5:294–300. doi: 10.1016/S1359-6446(00)01511-7. - DOI - PubMed
    1. Gordaliza M. Natural products as leads to anticancer drugs. Clin. Transl. Oncol. 2007;9:767–776. doi: 10.1007/s12094-007-0138-9. - DOI - PubMed
Feedback